[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"CMR Surgical Ltd\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":122},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,44,72,91],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100617276","versius-clinical-study-in-robot-assisted-inguinal-hernia-repair-surgery-100617276",false,"NCT07316517","Versius Clinical Study in Robot Assisted Inguinal Hernia Repair Surgery","Prospective Clinical Study to Evaluate the Safety and Efficacy of Versius in Robot-Assisted Inguinal Hernia Repair Surgery","Inclusion Criteria:\n\n1. Adult patients 22 years of age and older, deemed eligible for elective minimal invasive inguinal Hernia repair surgery.\n2. Patients providing written informed consent to participate in the study.\n\nExclusion Criteria:\n\n1. Patient unwilling to provide informed consent.\n2. Medical contraindication for general anaesthesia or minimally invasive procedure.\n3. Patient participation in an interventional clinical study that could impact primary outcomes results.\n4. Patient who falls into American Society of Anaesthesiologists (ASA) Class IV or above.\n5. Patients undergoing a concomitant surgical procedure.\n6. Contraindication for undergoing surgery with Versius (bleeding diathesis, active pregnancy or BMI ≥40 kg\u002Fm2).","ALL","22 Years",{"count":19,"type":20},30,"ESTIMATED","INTERVENTIONAL",[23],"NA","The objective of this clinical trial is to evaluate the safety and efficacy of Versius in Inguinal Hernia repair surgery",[26],"Robotic Assisted Inguinal Hernia Repair",[28,29,30],"Versius","Robotic surgery","Inguinal hernia","NOT_YET_RECRUITING","2025-12-18",{"date":34,"type":35},"2026-01-05","ACTUAL",{"date":37,"type":20},"2026-03",{"date":39,"type":20},"2026-12",{"name":41,"class":42},"CMR Surgical Ltd","INDUSTRY",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":51,"minAge":17,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":21,"phases":54,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":43},"100615183","versius-gynecology-study-100615183","NCT07289295","Versius Gynecology Study","Prospective Clinical Study to Evaluate the Safety and Efficacy of Versius in Robot-Assisted Total Hysterectomy","Inclusion Criteria:\n\n1. Female, aged 22 years or above, who provided written informed consent to participate in the study.\n2. Patient deemed suitable for minimally invasive total hysterectomy and\u002For Salpingo-Oophorectomy, for benign condition.\n3. Patient with BMI ≤40.\n\nExclusion Criteria:\n\n1. Patient unwilling to provide informed consent.\n2. Medical contraindication for general anaesthesia or minimally invasive procedure.\n3. Oncological cases, patient undergoing surgery or treatment for malignant disease.\n4. Clinically assessed Uterus size of \\> 14 pregnancy weeks (Estimated as \\> 14-15 cm longitudinal diameter).\n5. Patient participation in an interventional clinical study that could impact primary outcomes results.\n6. Patient who falls into American Society of Anaesthesiologists (ASA) Class IV or above (Appendix A).\n7. Uncontrolled hypertension, uncontrolled diabetes mellitus, or kidney failure.","FEMALE",{"count":53,"type":20},45,[23],"The objective of this clinical trial is to expand the clinical evaluation of the safety and efficacy of Versius in gynaecology procedures of total robotic assisted hysterectomy and\u002For salpingo-oophorectomy",[57],"Robotic Assisted Hysterectomy and\u002For Salpingo-oophorectomy",[28,59,60,61,62],"robotic surgery","hysterectomy","salpingo-oophrectomy","gynecology","RECRUITING","2025-12-04",{"date":66,"type":35},"2025-12-17",{"date":68,"type":35},"2025-07-25",{"date":70,"type":20},"2026-01",{"name":41,"class":42},{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":76,"acronym":4,"eligibilityCriteria":77,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":78,"targetDuration":4,"studyType":21,"phases":80,"briefSummary":81,"conditions":82,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":90,"locationsCount":4},"100600389","post-market-clinical-study-to-evaluate-the-performance-of-the-versius-surgical-system-100600389","NCT07096856","Post Market Clinical Study to Evaluate the Performance of the Versius Surgical System","Inclusion Criteria:\n\n* 1\\. Adult patients 22 years of age and older, eligible for soft tissue minimal access surgery, for cholecystectomy 2. Patients providing written informed consent to participate in the study\n\nExclusion Criteria:\n\n1. Patient unwilling to provide informed consent\n2. Patients undergoing surgery or treatment for malignant disease\n3. Patients undergoing a concomitant surgical procedure\n4. Medical contraindication for general anaesthesia or minimally invasive procedure\n5. Contraindication for undergoing surgery with Versius (Bleeding diathesis, Active pregnancy or BMI ≥40 kg\u002Fm2)",{"count":79,"type":20},100,[23],"The goal of this clinical trial is to learn how the Versius Surgical System, a robotic surgery device, works for gallbladder removal surgery (cholecystectomy) in adults. The main questions it aims to answer are:\n\nHow often can the surgery be successfully completed using Versius without needing to switch to a different surgical method?\n\nWhat serious complications, if any, occur within 30 days after surgery?\n\nResearchers will collect information from adult patients who have gallbladder surgery using the Versius system in U.S. hospitals. The purpose is to better understand how the device performs and how patients recover after surgery.\n\nParticipants will:\n\nBe adults age 22 or older who are eligible for minimally invasive gallbladder surgery\n\nUndergo robotic-assisted surgery using the Versius Surgical System\n\nAllow the research team to collect data during surgery and up to 30 days after\n\nComplete standard follow-up visits after discharge\n\nPatients with certain medical conditions, such as cancer, high BMI (≥40 kg\u002Fm²), or contraindications to anesthesia or robotic surgery, will not be included in the study.\n\nThis study is sponsored by CMR Surgical Ltd., the manufacturer of the Versius system.",[83],"Cholecystectomy, Robotic","2025-07-24",{"date":86,"type":35},"2025-07-31",{"date":88,"type":20},"2025-12",{"date":37,"type":20},{"name":41,"class":42},{"id":92,"slug":93,"hasResults":11,"nctId":94,"briefTitle":95,"officialTitle":96,"acronym":4,"eligibilityCriteria":97,"healthyVolunteers":11,"sex":16,"minAge":98,"maxAge":99,"enrollmentInfo":100,"targetDuration":4,"studyType":21,"phases":102,"briefSummary":103,"conditions":104,"keywords":106,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":121},"100557540","versius-paediatrics-study-100557540","NCT06539442","Versius Paediatrics Study","Prospective Clinical Study to Assess the Safety and Efficacy of Versius, in Urological Procedures in Paediatrics","Inclusion Criteria:\n\n* Patients, male or female, (\\\u003C18 years old) for whom an appropriate legal representative provides written consent for participation\n* Patient and disease factors deemed suitable for minimal access urological procedure\n* Multidisciplinary team (MDT) decision to treat with surgery\n* Patients under the care of the paediatric urology team in one of the participating centres\n\nExclusion Criteria:\n\n* Patients ≥ 18 years old\n* Appropriate legal representative unwilling to provide written consent\n* Medical contraindication for general anaesthesia\n* Medical contraindication for laparoscopic procedure\n* Active pregnancy (in post-pubertal female patients)\n* Morbid obesity (BMI ≥ 40 kg\u002Fm2)\n* Patient participation in an interventional clinical study, that could impact primary objectives results\n* Prior pelvic \u002Fabdominal radiotherapy treatment\n* Subjects with other clinically significant unstable medical disorder, life-threatening disease, or anything else in the opinion of the Investigator which would contra-indicate a surgical procedure","0 Years","17 Years",{"count":101,"type":20},150,[23],"This is prospective, multi-phase, single arm, multi-centre, multi-surgeon feasibility clinical trial to provide proof of concept and clinical evidence regarding the safety and efficacy of Versius (robotic surgery medical device) in Urological Procedures in Paediatric population. In alignment with IDEAL (Idea, Development, Exploration, Assessment, Long-term study) Framework, this study will consist of 3 main phases to ensure proper procedure development while ensuring patients safety. Feasibility and safety will be assessed on an ongoing basis, and specifically after completion of the first 3 procedures, at a single site (Southampton\u002FLead), each conducted one week apart to allow the identification of unanticipated risks\u002Fadverse events. Once deemed safe, based on the results of the 3 cases enrolled in Phase I, 7 further cases would be completed, at the same site. Once the procedure is deemed safe according to safety data collected, the recruitment will proceed to full trial patient accrual, 140 additional cases from the 3 participating study sites.The study patient population is children and adolescents under the age of 18, which will be provided clinical care and follow-ups per standard of care and hospital's policy.",[105],"Robotic Surgical Procedures in Pediatric Urology",[107,108,28,109,110,111,112],"Pediatric","Paediatric","Urology","Robotic assisted surgery","minimal access surgery","minimally invasive surgery","2024-10-09",{"date":115,"type":35},"2024-10-15",{"date":117,"type":35},"2024-07-08",{"date":119,"type":20},"2027-01-01",{"name":41,"class":42},3,""]